Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Presentation and management of a patient with subcutaneous metastatic transitional cell carcinoma of the bladder

Abstract

Background A 60-year-old female with a 6-month history of muscle-invasive transitional cell carcinoma of the bladder presented with an enlarging subcutaneous lesion involving her right flank. She had previously undergone radical cystectomy, bilateral pelvic lymphadenectomy and ileal orthotopic neobladder reconstruction.

Investigations Axial fused fluorodeoxyglucose PET–CT of the chest, abdomen and pelvis, fine needle aspiration with direct ultrasound guidance, excisional biopsy and immunohistochemistry.

Diagnosis Subcutaneous and liver metastases of transitional cell carcinoma.

Management Wide local excision of the subcutaneous lesion followed by combination gemcitabine–cisplatin chemotherapy. Gemcitabine was administered at a dose of 1,000 mg/m2 on days 1, 8, and 15, and cisplatin was administered at a dose of 75 mg/m2 on day 1; the schedule was repeated every 28 days for three cycles.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Fused fluorodeoxyglucose PET–CT scan.
Figure 2: Photomicrograph of the subcutaneous lesion.

References

  1. Krathen RA et al. (2003) Cutaneous metastasis: a meta-analysis of data. South Med J 96: 164–167

    Article  Google Scholar 

  2. Mueller TJ et al. (2004) Cutaneous metastases from genitourinary malignancies. Urology 63: 1021–1026

    Article  Google Scholar 

  3. Muntener M et al. (2007) Incidence of local recurrence and port site metastasis after laparoscopic radical nephroureterectomy. Urology 70: 864–868

    Article  Google Scholar 

  4. Wallmeroth A et al. (1999) Patterns of metastasis in muscle-invasive bladder cancer (pT2–4): an autopsy study on 367 patients. Urol Int 62: 69–75

    Article  CAS  Google Scholar 

  5. Chitale SV et al. (1997) Cutaneous metastases from transitional cell carcinomas of the bladder and renal pelvis. Br J Urol 79: 292–293

    Article  CAS  Google Scholar 

  6. Hassan JM et al. (2006) Patterns of initial transitional cell recurrence in patients after cystectomy. J Urol 175: 2054–2057

    Article  Google Scholar 

  7. Block CA et al. (2006) Cutaneous metastases from transitional cell carcinoma of the bladder. Urology 67: 846.e15–17

    Article  Google Scholar 

  8. Kumar PV et al. (2000) Subcutaneous metastasis from transitional cell carcinoma of the bladder diagnosed by fine needle aspiration biopsy. A case report. Acta Cytol 44: 657–660

    Article  CAS  Google Scholar 

  9. Somani BK et al. (2006) Herpetiform cutaneous metastases from transitional cell carcinoma of the urinary bladder: immunohistochemical analysis. J Clin Pathol 59: 1331–1333

    Article  CAS  Google Scholar 

  10. von der Maase H et al. (2005) Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 23: 4602–4608

    Article  CAS  Google Scholar 

  11. Roberts JT et al. (2006) Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer. Ann Oncol 17 (Suppl 5): v118–v122

    Article  Google Scholar 

  12. Gowardhan B et al. (2004) Twenty-three years of disease-free survival following cutaneous metastasis from a primary bladder transitional cell carcinoma. Int J Urol 11: 1031–1032

    Article  Google Scholar 

  13. Siefker-Radtke AO et al. (2004) Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience. J Urol 171: 145–148

    Article  Google Scholar 

  14. Kubota Y et al. (1998) Successful treatment of metastatic skin lesions with electrochemotherapy. J Urol 160: 1426

    Article  CAS  Google Scholar 

  15. Gallagher HJ et al. (1998) Hepatic resection of solitary metastasis from transitional cell carcinoma of the bladder. J Urol 159: 986

    Article  CAS  Google Scholar 

  16. Otto T et al. (2001) Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial. Urology 57: 55–59

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Trinity J Bivalacqua.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alphs, H., Miles-Thomas, J., Attenello, F. et al. Presentation and management of a patient with subcutaneous metastatic transitional cell carcinoma of the bladder. Nat Rev Urol 5, 691–694 (2008). https://doi.org/10.1038/ncpuro1253

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro1253

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing